Metabolomic profiling of reactive persulfides and polysulfides in the aqueous and vitreous humors
- PMID: 28169324
- PMCID: PMC5294455
- DOI: 10.1038/srep41984
Metabolomic profiling of reactive persulfides and polysulfides in the aqueous and vitreous humors
Abstract
We investigate the metabolomic profile of reactive persulfides and polysulfides in the aqueous and vitreous humors. Eighteen eyes of 18 consecutive patients with diabetes mellitus (DM) and diabetic retinopathy underwent microincision vitrectomy combined with cataract surgery. Samples of the aqueous and vitreous humors were collected and underwent mass spectrometry-based metabolomic profiling of reactive persulfides and polysulfides (polysulfidomics). The effect of reactive polysulfide species on the viability of immortalized retinal cells (the RGC-5 cell line) under oxidative stress (induced with H2O2) was also evaluated with an Alamar Blue assay. The experiments showed that cysteine persulfides (CysSSH), oxidized glutathione trisulfide (GSSSG) and cystine were elevated in the aqueous humor, and CysSSH, Cys, and cystine were elevated in the vitreous. Furthermore, GSSSG, cystine, and CysSSH levels were correlated in the aqueous and vitreous humors. A comparison, in DM and control subjects, of plasma levels of reactive persulfides and polysulfides showed that they did not differ. In vitro findings revealed that reactive polysulfide species increased cell viability under oxidative stress. Thus, various reactive persulfides and polysulfides appear to be present in the eye, and some reactive sulfide species, which have a protective effect against oxidative stress, are upregulated in the aqueous and vitreous humors of DM eyes.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
References
-
- Whiting D. R., Guariguata L., Weil C. & Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical practice 94, 311–321 (2011). - PubMed
-
- Ruta L. M. et al. Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabetic medicine: a journal of the British Diabetic Association 30, 387–398 (2013). - PubMed
-
- Virgili G., Parravano M., Menchini F. & Evans J. R. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev. CD007419 (2014). - PubMed
-
- Schoenberger S. D. et al. Outcomes of 25-gauge pars plana vitrectomy in the surgical management of proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging 42, 474–480 (2011). - PubMed
-
- Shimura M. et al. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol 145, 854–861 (2008). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
